Therapeutic Conundrum: Infective Endocarditis due to Extensively Drug-resistant Pseudomonas aeruginosa Treated with Ceftazidime/Avibactam Monotherapy: A Case Report-Reference-Cited by-同舟云学术

Therapeutic Conundrum: Infective Endocarditis due to Extensively Drug-resistant Pseudomonas aeruginosa Treated with Ceftazidime/Avibactam Monotherapy: A Case Report

Published:2023-08-18 Issue:4 Volume:2 Page:88-90
ISSN:
Container-title:Indian Journal of Critical Care Case Report
language:en
Short-container-title:

Author:

Dawra Romika,Patwardhan Sampada,Prayag Amrita,Prayag Parikshit S,Ajapuje Preeti,Sathe Shireesh,Kanase Dhairyasheel,Javdekar Narendra,Juvekar Nilesh,Melinkeri Advait

Publisher

Jaypee Brothers Medical Publishing

Subject

General Medicine,Microbiology (medical),Immunology,Immunology and Allergy,General Agricultural and Biological Sciences,General Earth and Planetary Sciences,General Environmental Science,Automotive Engineering,Industrial and Manufacturing Engineering,General Medicine,General Medicine,General Medicine,General Medicine

Link

http://www.ijccr.org/doi/pdf/10.5005/jp-journals-11006-0061

Reference13 articles.

1. 1. Bouza E, Muñoz P, Burillo A. Gram-negative endocarditis: disease presentation, diagnosis and treatment. Curr Opin Infect Dis 2021;34(6):672–680. DOI: 10.1097/QCO.0000000000000788

2. 2. Reyes MP, Reyes KC. Gram-negative endocarditis. Curr Infect Dis Rep 2008;10(4):267–274. DOI: 10.1007/s11908-008-0044-5

3. 3. Murdoch DR, Corey GR, Hoen B, et al. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the international collaboration on endocarditis-prospective cohort study. Arch Intern Med 2009;169(5):463–473. DOI: 10.1001/archinternmed.2008.603

4. 4. Morpeth S, Murdoch D, Cabell CH, et al. Non-HACEK gram-negative bacillus endocarditis. Ann Intern Med 2007;147(12):829–835. DOI: 10.7326/0003-4819-147-12-200712180-00002

5. 5. Falcone M, Tiseo G, Durante-Mangoni E, et al. Risk factors and outcomes of endocarditis due to non-HACEK gram-negative bacilli: data from the prospective multicenter Italian endocarditis study cohort. Antimicrob Agents Chemother 2018;62(4):e02208–e02217. DOI: 10.1128/AAC.02208-17